Behavioral
Minuteclinic Diagnostic of Virginia LLC
Minuteclinic Diagnostic of Virginia LLC was paid $9.01M by Medicaid between Jan 2018 and Dec 2024, across 83 billing codes. Its largest line is 99211, Office or other outpatient visit for the evaluation and management of an established patient, minimal severity — 24% of everything it billed.
33Billing provider infoMINUTECLINIC DIAGNOSTIC OF VIRGINIA LLC
LEESBURG, VA 20176
LEESBURG, VA 20176
33aNPI1417076829assigned 03/28/2007
33bProvider typeProfessional Counselor
28Total paid$9.01M
24GClaims559,617
24DCodes billed83
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Professional Counselor providers in Virginia
Rank by total paid#6 of 364
Median peer was paid$52K
This provider vs. median173×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PINCINCE, DEBORAH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,707 | $305K | |
| 2019 | 17,045 | $523K | |
| 2020 | 55,166 | $899K | |
| 2021 | 172,788 | $2.80M | |
| 2022 | 132,793 | $1.97M | |
| 2023 | 93,482 | $1.32M | |
| 2024incomplete | 79,636 | $1.21M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 24% | 174,615 | 153,502 | $2.13M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 16% | 56,489 | 48,806 | $1.40M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 21,119 | 18,976 | $1.11M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 10% | 14,477 | 13,643 | $916K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.8% | 10,667 | 9,517 | $705K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4.0% | 8,489 | 7,848 | $358K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.2% | 17,677 | 15,804 | $196K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.1% | 6,325 | 5,933 | $189K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.0% | 6,336 | 5,656 | $184K |
| 99401 | 1.4% | 5,533 | 5,247 | $123K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.2% | 1,704 | 1,592 | $107K |
| 90715 | 1.1% | 3,248 | 3,042 | $102K |
71 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.0% | 8,042 | $91K |
| 86580 | <1% | 12,428 | $88K | |
| 90674 | <1% | 4,737 | $79K | |
| 3074F | <1% | 25,507 | $77K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 689 | $67K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,059 | $65K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,658 | $65K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 17,117 | $62K |
| 3078F | <1% | 20,821 | $61K | |
| 90750 | <1% | 527 | $60K | |
| 90739 | <1% | 392 | $54K | |
| 1160F | <1% | 24,981 | $51K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,327 | $47K |
| 1159F | <1% | 22,449 | $47K | |
| 90686 | <1% | 3,148 | $41K | |
| 91322 | <1% | 339 | $40K | |
| 90746 | <1% | 798 | $38K | |
| 1036F | <1% | 29,757 | $37K | |
| 91320 | <1% | 336 | $36K | |
| 90716 | <1% | 369 | $35K | |
| 3008F | <1% | 23,104 | $35K | |
| 90651 | <1% | 188 | $30K | |
| 90734 | <1% | 431 | $27K | |
| 3079F | <1% | 8,150 | $27K | |
| 90619 | <1% | 306 | $26K | |
| 90682 | <1% | 631 | $20K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,092 | $19K |
| 90707 | <1% | 305 | $16K | |
| 0064A | <1% | 488 | $13K | |
| 90661 | <1% | 398 | $11K | |
| 3075F | <1% | 3,318 | $11K | |
| 99201 | <1% | 362 | $9K | |
| 0081A | <1% | 302 | $8K | |
| 90480 | <1% | 780 | $7K | |
| 81002 | <1% | 3,146 | $7K | |
| 0004A | <1% | 277 | $7K | |
| 0082A | <1% | 218 | $6K | |
| 0134A | <1% | 201 | $6K | |
| 0071A | <1% | 167 | $6K | |
| 90713 | <1% | 165 | $5K | |
| 90656 | <1% | 256 | $5K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,519 | $5K |
| 3077F | <1% | 1,433 | $5K | |
| 0001A | <1% | 170 | $5K | |
| 3080F | <1% | 1,091 | $4K | |
| 0072A | <1% | 113 | $4K | |
| 81025 | <1% | 563 | $3K | |
| 99402 | <1% | 151 | $3K | |
| 0124A | <1% | 104 | $3K | |
| 90662 | <1% | 319 | $3K | |
| 0011A | <1% | 109 | $3K | |
| 0083A | <1% | 103 | $3K | |
| 0002A | <1% | 95 | $3K | |
| 90673 | <1% | 32 | $2K | |
| 0031A | <1% | 53 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 518 | $1K |
| 0074A | <1% | 30 | $778.99 | |
| 90632 | <1% | 17 | $718.54 | |
| 80061 | Lipid panel | <1% | 35 | $430.27 |
| 0012A | <1% | 14 | $400.47 | |
| 86328 | <1% | 34 | $310.76 | |
| G0008 | Administration of influenza virus vaccine | <1% | 146 | $98.42 |
| 82947 | <1% | 41 | $94.48 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 12 | $11.92 |
| 91308 | 0% | 163 | $0.00 | |
| 4040F | 0% | 14 | $0.00 | |
| 4120F | 0% | 57 | $0.00 | |
| 91300 | 0% | 32 | $0.00 | |
| 91313 | 0% | 17 | $0.00 | |
| 4124F | 0% | 145 | $0.00 | |
| 1000F | 0% | 42 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPINCINCE, DEBORAH (ADMINISTRATOR)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.